| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1470-2045(01)00622-2 |
| P698 | PubMed publication ID | 11905606 |
| P2093 | author name string | Seiji Yano | |
| Corazon D Bucana | |||
| Isaiah J Fidler | |||
| Ruo-Dan Zhang | |||
| Takahashi Fujimaki | |||
| P2860 | cites work | Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Evidence for a blood-brain barrier defect | Q48186495 |
| The blood-brain barrier redefined | Q48313750 | ||
| The importance of brain temperature in alterations of the blood-brain barrier following cerebral ischemia. | Q48903817 | ||
| Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat. | Q49154018 | ||
| Angiogenesis and blood-brain barrier breakdown modulate CT contrast enhancement: an experimental study in a rabbit brain-tumor model | Q50887606 | ||
| The endothelial hyperplasia of the cerebral blood vessels with brain tumors, and its sarcomatous transformation | Q51322265 | ||
| Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. | Q55476886 | ||
| Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells | Q67590241 | ||
| Metastasis results from preexisting variant cells within a malignant tumor | Q67602509 | ||
| Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis | Q71459931 | ||
| Surgical treatment of metastatic brain tumors | Q71629204 | ||
| Evidence for the clonal origin of spontaneous metastases | Q72041683 | ||
| Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation | Q24642901 | ||
| Angiogenesis in cancer and other diseases | Q27861015 | ||
| TIE1 and TIE2 Receptor Tyrosine Kinases Inversely Regulate Embryonic Angiogenesis by the Mechanism of Intussusceptive Microvascular Growth | Q28512487 | ||
| Mechanisms of angiogenesis | Q29547485 | ||
| Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene | Q29547732 | ||
| Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | Q29547733 | ||
| The distribution of secondary growths in cancer of the breast. 1889 | Q29614314 | ||
| Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid | Q29617640 | ||
| VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain | Q30936721 | ||
| Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells | Q34047111 | ||
| Delivery of molecular and cellular medicine to solid tumors | Q34190339 | ||
| The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour | Q36037858 | ||
| Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation | Q36618743 | ||
| Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF 121 and VEGF 165 but not VEGF 189 | Q36636478 | ||
| The physiology of the blood-brain barrier. | Q37990987 | ||
| Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis | Q40377374 | ||
| Modulation of the organ microenvironment for treatment of cancer metastasis | Q40415645 | ||
| Antibody-directed targeting of the vasculature of solid tumors | Q40930942 | ||
| Clonal origin of metastasis in B16 murine melanoma: a cytogenetic study | Q43417858 | ||
| Development ofin vivo models for studies of brain metastasis | Q48088030 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 53-57 | |
| P577 | publication date | 2002-01-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Lancet Oncology Commission | Q13747613 |
| P1476 | title | The seed and soil hypothesis: vascularisation and brain metastases | |
| P478 | volume | 3 |
| Q33840723 | "Pre-metastatic niches" in breast cancer: are they created by or prior to the tumour onset? "Flammer Syndrome" relevance to address the question. |
| Q94465319 | A Pilot Study: N-Staging Assessment of Shear Wave Elastrography in Small Cervical Lymph Nodes for Nasopharyngeal Carcinoma |
| Q34000987 | A Review of Current Management of Brain Metastases |
| Q44496375 | A novel concept of glomeruloid body formation in experimental cerebral metastases |
| Q73245873 | A novel rodent mammary window of orthotopic breast cancer for intravital microscopy |
| Q35009151 | A two-stage model for in vivo assessment of brain tumor perfusion and abnormal vascular structure using arterial spin labeling |
| Q34731651 | Activation of the kinin B1 receptor attenuates melanoma tumor growth and metastasis |
| Q29308099 | Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? |
| Q31014801 | Allelic diversity in the host genetic background may be an important determinant in tumor metastatic dissemination |
| Q27322772 | An Integrative Platform for Three-dimensional Quantitative Analysis of Spatially Heterogeneous Metastasis Landscapes |
| Q42824566 | An experimental study on the Chinese lung adenocarcinoma cell clone CPA-Yang1-BR with brain metastasis potency in nude mice and in vivo imaging research |
| Q60895177 | Analysis of nanoparticle delivery to tumours |
| Q36887534 | Angiogenesis in brain tumours |
| Q38034321 | Angiogenesis in neurological disorders: a review |
| Q38985337 | Anti-angiogenetic therapies for central nervous system metastases from non-small cell lung cancer. |
| Q37187003 | Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance. |
| Q34457363 | Apoptotic cells initiate endothelial cell sprouting via electrostatic signaling |
| Q57176317 | Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine |
| Q91830356 | Bevacizumab in Combination with Pemetrexed and Platinum Significantly Improved the Clinical Outcome of Patients with Advanced Adenocarcinoma NSCLC and Brain Metastases |
| Q38059028 | Biology of brain metastases and novel targeted therapies: Time to translate the research |
| Q37810222 | Biomarkers in Cancer Micrometastasis: Where are We At? |
| Q28304943 | Biophysics of selectin–ligand interactions in inflammation and cancer |
| Q36558683 | Blood-brain barrier and chemotherapeutic treatment of brain tumors |
| Q35781600 | Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy |
| Q37217055 | Blood-brain barrier remodeling during brain metastasis formation |
| Q51193862 | Brain Metastases Research 1990–2010: Pattern of Citation and Systematic Review of Highly Cited Articles |
| Q38084825 | Brain Metastases from Colorectal Cancer: Microenvironment and Molecular Mechanisms |
| Q33760569 | Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors |
| Q84027206 | Brain metastases in breast cancer. Epidemiology and natural history. The Institut Curie experience |
| Q35728733 | Brain metastases in lung cancer |
| Q38233149 | Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches |
| Q92134610 | Brain metastases in oncogene-driven non-small cell lung cancer |
| Q54593723 | Brain metastasis of breast tumors and blood brain barrier |
| Q53109741 | Brain metastatic volume and white matter lesions in advanced cancer patients |
| Q30238959 | Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context. |
| Q37593526 | Breast cancer causes and treatment: where are we going wrong? |
| Q36299200 | CXCR4 Expression Predicts Early Liver Recurrence and Poor Survival After Resection of Pancreatic Adenocarcinoma |
| Q38450227 | Cancer dissemination: a consequence of limited carrying capacity? |
| Q64889128 | Cancer-Associated Fibroblasts Enhance Survival and Progression of the Aggressive Pancreatic Tumor Via FGF-2 and CXCL8. |
| Q35605745 | Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status |
| Q36560327 | Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms. |
| Q36804855 | Characterization of the melanoma brain metastatic niche in mice and humans |
| Q58297721 | Chemotherapy in brain metastases of lung and breast cancer |
| Q40157491 | Chronic headache as the first symptom of an undiagnosed renal cell carcinoma. |
| Q37027492 | Circulating tumor cells: detection, molecular profiling and future prospects |
| Q36313559 | Clinical outcome and molecular characterization of brain metastases from esophageal and gastric cancer: a systematic review. |
| Q64980229 | Comparison of Voxel-Wise Tumor Perfusion Changes Measured With Dynamic Contrast-Enhanced (DCE) MRI and Volumetric DCE CT in Patients With Metastatic Brain Cancer Treated with Radiosurgery. |
| Q38511670 | Control of the blood-brain barrier function in cancer cell metastasis |
| Q33710152 | Critical appraisal of the role of gefitinib in the management of locally advanced or metastatic non-small cell lung cancer |
| Q52709759 | Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases |
| Q36452704 | Current status and perspective of angiogenesis and antivascular therapeutic strategy: non-small cell lung cancer |
| Q43518666 | Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the Eleventh Annual Blood-Brain Barrier Consortium meeting |
| Q34770149 | Detection and isolation of circulating tumor cells in urologic cancers: a review |
| Q36820588 | Development of a preclinical therapeutic model of human brain metastasis with chemoradiotherapy. |
| Q27023250 | Developmental and pathological angiogenesis in the central nervous system |
| Q48130398 | Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and br |
| Q40142106 | Downregulation of missing in metastasis gene (MIM) is associated with the progression of bladder transitional carcinomas |
| Q33997439 | Drug delivery to brain tumours: challenges and progress |
| Q39519242 | Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma |
| Q39644572 | Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases |
| Q39178057 | Embelin Induces Apoptosis in Human Glioma Cells Through Inactivating NF-κB |
| Q38953017 | Embracing rejection: Immunologic trends in brain metastasis |
| Q37356182 | Emerging role of brain metastases in the prognosis of breast cancer patients |
| Q52591097 | Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non-Small Cell Lung Cancer. |
| Q38763111 | Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future |
| Q28084034 | Epidermal growth factor signaling in transformed cells |
| Q37708851 | Epigenetic therapy potential of suberoylanilide hydroxamic acid on invasive human non-small cell lung cancer cells |
| Q92107306 | Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts |
| Q78708143 | Evidence for the causal role of endogenous interferon-alpha/beta in the regulation of angiogenesis, tumorigenicity, and metastasis of cutaneous neoplasms |
| Q36562978 | Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model |
| Q33685045 | Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma. |
| Q34014165 | Fluid Shear Stress Sensitizes Cancer Cells to Receptor-Mediated Apoptosis via Trimeric Death Receptors |
| Q35549471 | Functional imaging of angiogenesis in an orthotopic model of pancreatic cancer |
| Q58780492 | Gamma Knife Radiosurgery for Metastatic Brain Tumors with Exophytic Hemorrhage |
| Q48494333 | Gefitinib Alone or with Concomitant Whole Brain Radiotherapy for Patients with Brain Metastasis from Non-small-cell Lung Cancer: A Retrospective Study |
| Q33699188 | Gene targeting to the stroma of the prostate and bone |
| Q33350614 | Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management |
| Q73331440 | Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population |
| Q35028835 | High prevalence of human cytomegalovirus in brain metastases of patients with primary breast and colorectal cancers |
| Q37078073 | High-resolution in vivo imaging of fluorescent proteins using window chamber models. |
| Q36853759 | Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor |
| Q33767336 | Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12. |
| Q36116059 | Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells |
| Q36589929 | IL-6 Receptor Is a Possible Target against Growth of Metastasized Lung Tumor Cells in the Brain |
| Q89449724 | Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer |
| Q83021259 | Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study |
| Q39282637 | Imaging the efficacy of UVC irradiation on superficial brain tumors and metastasis in live mice at the subcellular level |
| Q48138180 | Immunoexpression of endoglin in brain metastasis secondary to malignant melanoma: evaluation of angiogenesis and comparison with brain metastasis secondary to breast and lung carcinomas |
| Q42378527 | Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy |
| Q36563082 | Impact of serum vascular endothelial growth factor on prognosis in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization |
| Q36166098 | In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro |
| Q38074351 | In vivo animal models for studying brain metastasis: value and limitations |
| Q47136514 | In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs. |
| Q36006105 | Influences of brain tumor-associated pH changes and hypoxia on epileptogenesis |
| Q36259629 | Inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation on tumor-associated endothelial cells leads to treatment of orthotopic human colon cancer in nude mice |
| Q36590195 | Innovative therapeutic strategies in the treatment of brain metastases |
| Q37446669 | Integrin-mediated regulation of neurovascular development, physiology and disease |
| Q34388791 | Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis |
| Q35842672 | Intravenous, non-viral RNAi gene therapy of brain cancer |
| Q55239612 | Inverse Perfusion Requirements of Supra- and Infratentorial Brain Metastases Formation. |
| Q34048921 | Lack of Angiogenesis in Experimental Brain Metastases |
| Q37223917 | Long-lasting response to crizotinib in brain metastases due to EML4-ALK-rearranged non-small-cell lung cancer. |
| Q42339666 | Long-lasting response to third-line crizotinib treatment in a patient with non-small cell lung cancer with brain metastases and poor performance status. |
| Q34701110 | Longitudinal MRI Evaluation of Intracranial Development and Vascular Characteristics of Breast Cancer Brain Metastases in a Mouse Model |
| Q34347733 | Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy. |
| Q83008844 | Mechanisms of metastasis |
| Q52559905 | Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease |
| Q41957492 | Menadione : Sodium Orthovanadate Combination Eliminates and Inhibits Migration of Detached Cancer Cells |
| Q38237985 | Metastasis review: from bench to bedside |
| Q29614295 | Metastasis: from dissemination to organ-specific colonization |
| Q55295930 | Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid Transporter Mfsd2a. |
| Q58734063 | MiR-423-5p in brain metastasis: potential role in diagnostics and molecular biology |
| Q27022292 | MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives |
| Q95797987 | Miliary brain metastases from primary gastric small cell carcinoma: illustrating the seed and soil hypothesis |
| Q39172101 | Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146. |
| Q26800626 | Molecular and Genetic Predictors of Breast-to-Brain Metastasis: Review and Case Presentation |
| Q35161738 | Molecular mechanisms of angiogenesis in non-small cell lung cancer, and therapeutics targeting related molecules |
| Q36322783 | Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis. |
| Q37579928 | Multimodal imaging enables early detection and characterization of changes in tumor permeability of brain metastases |
| Q38081808 | Multiple brain metastases - current management and perspectives for treatment with electrochemotherapy |
| Q97652827 | Nephronectin promotes breast cancer brain metastatic colonization via its integrin-binding domains |
| Q36492361 | Neuroprotection in primary brain tumors: sense or nonsense? |
| Q59611008 | Non-randomness of the anatomical distribution of tumors |
| Q38811717 | Noninvasive imaging of the functional effects of anti-VEGF therapy on tumor cell extravasation and regional blood volume in an experimental brain metastasis model |
| Q37923386 | Novel approaches to treating leptomeningeal metastases |
| Q36639760 | Occurrence of cancer at multiple sites: towards distinguishing multigenesis from metastasis |
| Q37396904 | Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4. |
| Q26851813 | Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery |
| Q46085756 | Optimal Visualization of Multiple Brain Metastases for Gamma Knife Radiosurgery |
| Q35828652 | Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells |
| Q40171936 | Orthotopic hepatocellular carcinoma model with a controlled and reproducible tumorigenicity |
| Q38281325 | Pathogenesis of Breast Cancer Metastasis to Brain: a Comprehensive Approach to the Signaling Network |
| Q93136766 | Patterns of brain metastasis in anaplastic lymphoma kinase - rearranged and epidermal growth factor receptor-mutated lung cancer patients in magnetic resonance imaging |
| Q39601099 | Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent |
| Q59790152 | Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer |
| Q38707035 | Phosphatidylserine-Targeted Nanotheranostics for Brain Tumor Imaging and Therapeutic Potential |
| Q24644787 | Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors |
| Q38513023 | Possible pathophysiological role of vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in metastatic brain tumor-associated intracerebral hemorrhage |
| Q39651776 | Preniche as missing link of the metastatic niche concept explaining organ-preferential metastasis of malignant tumors and the type of metastatic disease |
| Q102059890 | Prognosis of metastasis based on age and serum analytes after follow-up of non-metastatic lung cancer patients |
| Q35811557 | Prognostic Value of VEGF in Hepatocellular Carcinoma Patients Treated with Sorafenib: A Meta-Analysis. |
| Q37646729 | Rapid intracranial response to osimertinib, without radiotherapy, in nonsmall cell lung cancer patients harboring the EGFR T790M mutation: Two Case Reports |
| Q34105366 | Reactive Astrocytes Protect Melanoma Cells from Chemotherapy by Sequestering Intracellular Calcium through Gap Junction Communication Channels |
| Q33519908 | Real-time imaging reveals the single steps of brain metastasis formation |
| Q54962187 | Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussion. |
| Q43864998 | Renal carcinoma: point on treatment of brain metastasis |
| Q58577411 | Risk factors for brain metastases in patients with non-small-cell lung cancer |
| Q37697247 | Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma |
| Q38052756 | Role of the systemic immune system in brain metastasis |
| Q38110297 | Seed, soil, and beyond: The basic biology of brain metastasis |
| Q45929008 | Spatial brain distribution of intra-axial metastatic lesions in breast and lung cancer patients. |
| Q93062858 | Spz/Toll-6 signal guides organotropic metastasis in Drosophila |
| Q40784455 | Surgery for brain metastases |
| Q38738053 | Systemic therapies in the treatment of non-small-cell lung cancer brain metastases |
| Q39123945 | T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting |
| Q38056876 | The Biology of Brain Metastasis |
| Q43969265 | The Brain Microenvironment and Cancer Metastasis |
| Q26801841 | The Contribution of Angiogenesis to the Process of Metastasis |
| Q35864968 | The Molecular Biology of Brain Metastasis |
| Q35676602 | The biology of brain metastases-translation to new therapies |
| Q36322825 | The challenge of targeting metastasis |
| Q35684114 | The physics of cancer: the role of physical interactions and mechanical forces in metastasis |
| Q38132400 | The role of epidermal growth factor receptor in cancer metastasis and microenvironment |
| Q34784896 | The seed and soil hypothesis revisited—The role of tumor‐stroma interactions in metastasis to different organs |
| Q27348725 | The vascular basement membrane as "soil" in brain metastasis |
| Q48445989 | Therapeutics for Brain Metastases, v3. |
| Q37809862 | Therapy and prophylaxis of brain metastases |
| Q33805406 | Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies |
| Q53022125 | Tumor Cells and Micro-environment in Brain Metastases |
| Q36616513 | Tumor dormancy and the role of metastasis suppressor genes in regulating ectopic growth |
| Q37016936 | Tumor microenvironment in the brain |
| Q51461588 | Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib |
| Q91576998 | Unified platform for multimodal voxel-based analysis to evaluate tumour perfusion and diffusion characteristics before and after radiation treatment evaluated in metastatic brain cancer |
| Q64099003 | Up-regulation of Insulin-like Growth Factor Binding Protein-3 Is Associated with Brain Metastasis in Lung Adenocarcinoma |
| Q33424301 | VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer |
| Q40550921 | Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice |
| Q37564297 | Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature |
| Q33996790 | Vascular gene expression patterns are conserved in primary and metastatic brain tumors |
| Q36110975 | Vascular instruction of pancreas development |
| Q39793584 | Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks |
| Q36286366 | Zoledronic acid is effective in preventing and delaying skeletal events in patients with bone metastases secondary to genitourinary cancers |
| Q35609031 | mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine |
Search more.